{"nct_id":"NCT00249808","title":"A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2004-12-13","start_date_type":"ACTUAL","primary_completion_date":"2007-01-25","primary_completion_date_type":"ACTUAL","completion_date":"2007-01-25","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["MRK"]}